Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.Journal of Pharmacokinetics and Biopharmaceutics|July 29, 1998
A semiparametric method for describing noisy population pharmacokinetic dataK Park, D Verotta, T F Blaschke, et al.Clinical Pharmacology and Therapeutics|April 29, 1998
Passive versus electrotransport-facilitated transdermal absorption of ketorolacK Park, D Verotta, S K Gupta, et al.Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1989
A semiparametric approach to physiological flow modelsD Verotta, L B Sheiner, W F Ebling, et al.Clinical Pharmacology and Therapeutics|January 1, 1997
A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complexJ M Gries, I F Troconiz, D Verotta, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1991
Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical modelD Verotta, J Kitts, R Rodriguez, et al.The American Journal of Physiology|October 1, 1996
Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antideK E Fattinger, D Verotta, H C Porchet, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1987
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in manJ Schüttler, D R Stanski, P F White, et al.Antimicrobial Agents and Chemotherapy|November 26, 1997
Exposure-response relationships for saquinavir, zidovudine, and zalcitabine in combination therapyG F Vanhove, J M Gries, D Verotta, et al.Clinical Pharmacology and Therapeutics|October 1, 1989
The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral doseR A Boyd, S K Chin, O Don-Pedro, et al.Pageof 15